Latest News

A Newcastle medtech company has secured nearly £250,000 in funding from Innovate UK to further its research into the impact of genetics on implants.

Read the rest of entry »

Inivata, a leader in liquid biopsy, is pleased to announce that Dr. Nitzan Rosenfeld, Co-founder and Chief Scientific Officer at Inivata has been announced the winner of the 2020 Pezcoller Foundation European Association for Cancer Research (EACR) Cancer Researcher Award.  

Read the rest of entry »

AMSBIO offers a Skeletal Muscle Differentiation kit that enables you to differentiate human pluripotent stem cells to skeletal muscle myotubes with high yields, without cell sorting or genetic manipulation. Myotubes are contractile, express typical muscle markers that show striated sarcomeres.

Read the rest of entry »

Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, today announced a partnership with the Technical University of Denmark to develop engineered recombinant antibodies specific for animal toxins, such as toxins from snake venoms.

Read the rest of entry »

Arctoris Ltd, an Oxford-based company that operates the world’s first fully automated drug discovery platform, has announced the 2nd edition of BioTarget, a global business competition for drug discovery entrepreneurs. BioTarget 2020 is now open for applications.

Read the rest of entry »

Domainex Ltd., a fully integrated provider of drug discovery services from its Medicines Research Centre near Cambridge, UK, has entered into a research partnership with LUNAC Therapeutics Limited to discover novel anticoagulant therapies that have a reduced risk of bleeding compared to current therapies.

Read the rest of entry »

Arecor Ltd, the biopharmaceutical company advancing today’s therapies to enable healthier lives, today announces that it has achieved an important second, contractual milestone with one of its pharmaceutical partners. The first milestone was triggered in October 2017 following the signature of a license agreement between the parties.

Read the rest of entry »

Discovery Park, the thriving science park for  ambitious and growing life sciences companies, has been named a Life Sciences Opportunity Zone (LSOZ) by the UK Government’s Office for Life Sciences.

Read the rest of entry »

A spin-out from Imperial College, Accunea has developed vital organ transplant technology that will make available more organs for transplant and reduce the numbers of deaths due to increasing waiting list times.

Read the rest of entry »

European law firm, Fieldfisher advised on £34 million (€40.3 million) worth of venture capital deals in the life sciences sector, last year.

Read the rest of entry »